Pfizer Inc. (PFE) Announces Positive Topline Results From Phase 3 TALAPRO-3 Study of TALZENNA®.
Share this article
Corporate
Score 85
Bullish
Pfizer Inc. (PFE) Announces Positive Topline Results From Phase 3 TALAPRO-3 Study of TALZENNA®
Mar 25, 2026 18:52 UTC
PFE, XLV, IJK
Short term
Related Articles
Score 85
Bullish
Brown-Forman’s stock soared on deal talks. Its valuation had tumbled to financial-crisis levels.
Mar 27, 08:09
Score 65
Helium Shortage Sparks Widespread Concerns Beyond Birthday Parties
Mar 27, 08:00
Score 45
Bullish
Santander’s Botin Sees Efficiency Improving in First Quarter
Mar 27, 07:11
Score 85
Bullish
AI Breakthrough From Google Exposes Divide in Memory Chip Stocks
Mar 27, 05:59
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.